Mark Goldin

1.2k total citations
29 papers, 349 citations indexed

About

Mark Goldin is a scholar working on Internal Medicine, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mark Goldin has authored 29 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Internal Medicine, 13 papers in Infectious Diseases and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mark Goldin's work include Venous Thromboembolism Diagnosis and Management (20 papers), COVID-19 Clinical Research Studies (11 papers) and COVID-19 and healthcare impacts (8 papers). Mark Goldin is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (20 papers), COVID-19 Clinical Research Studies (11 papers) and COVID-19 and healthcare impacts (8 papers). Mark Goldin collaborates with scholars based in United States, Canada and Russia. Mark Goldin's co-authors include Alex C. Spyropoulos, Dimitrios Giannis, Thomas McGinn, Stuart L. Cohen, Eugenia Gianos, Jamie S. Hirsch, Nina Kohn, Saurav Chatterjee, Kevin Coppa and Linqi Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Mark Goldin

27 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Goldin United States 12 198 166 84 72 71 29 349
Susan Louw South Africa 8 79 0.4× 71 0.4× 9 0.1× 55 0.8× 8 0.1× 38 273
Shu‐Mei Chang Taiwan 9 124 0.6× 19 0.1× 27 0.3× 7 0.1× 14 0.2× 17 394
Luigi Atripaldi Italy 10 147 0.7× 5 0.0× 60 0.7× 15 0.2× 44 0.6× 39 341
Xiaoqing Wu China 11 184 0.9× 55 0.3× 82 1.0× 55 0.8× 51 476
Ana Luiza Schneider Moreira Brazil 11 96 0.5× 15 0.1× 53 0.6× 8 0.1× 40 0.6× 22 324
Mehrdad Rostami Iran 8 228 1.2× 38 0.2× 63 0.8× 98 1.4× 19 359
Matthew W. McClure United States 10 113 0.6× 125 0.8× 14 0.2× 8 0.1× 2 0.0× 21 561
Pek Yoon Chong Singapore 6 582 2.9× 55 0.3× 142 1.7× 214 3.0× 8 746
Charlotte Kaeuffer France 9 207 1.0× 38 0.2× 87 1.0× 86 1.2× 19 296
Thor Håkon Skattør Norway 3 360 1.8× 233 1.4× 28 0.3× 1 0.0× 152 2.1× 9 1.0k

Countries citing papers authored by Mark Goldin

Since Specialization
Citations

This map shows the geographic impact of Mark Goldin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Goldin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Goldin more than expected).

Fields of papers citing papers by Mark Goldin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Goldin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Goldin. The network helps show where Mark Goldin may publish in the future.

Co-authorship network of co-authors of Mark Goldin

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Goldin. A scholar is included among the top collaborators of Mark Goldin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Goldin. Mark Goldin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goldin, Mark, et al.. (2025). Reversal of Direct Oral Anticoagulants (DOACs) for Critical Bleeding or Urgent Procedures. Journal of Clinical Medicine. 14(3). 1013–1013. 1 indexed citations
2.
Goldin, Mark, Tungming Leung, Sejal B. Shah, et al.. (2024). Clinical Pathways and Outcomes of Andexanet Alfa Administration for the Reversal of Critical Bleeding in Patients on Oral Direct Factor Xa Inhibitors. SHILAP Revista de lepidopterología. 8(2). e209–e215. 3 indexed citations
3.
4.
Piazza, Gregory, Alex C. Spyropoulos, Judith Hsia, et al.. (2023). Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial. Circulation. 147(25). 1891–1901. 15 indexed citations
5.
Giannis, Dimitrios, Mark Goldin, Husneara Rahman, et al.. (2023). Risk Factors for Postdischarge Major Thromboembolism and Mortality in Hospitalized Patients with COVID-19 with Cardiovascular Comorbidities: Insights from the CORE-19 Registry. Thrombosis and Haemostasis. 123(11). 1089–1099. 2 indexed citations
6.
Goldin, Mark, et al.. (2023). Antithrombotic therapy in the management of hospitalised patients with COVID-19. British Journal of Hospital Medicine. 84(5). 1–11.
7.
Spyropoulos, Alex C., Jean M. Connors, James D. Douketis, et al.. (2022). Good practice statements for antithrombotic therapy in the management of COVID‐19: Guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 20(10). 2226–2236. 24 indexed citations
8.
Spyropoulos, Alex C., Mark Goldin, Walter Ageno, et al.. (2022). Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial. SHILAP Revista de lepidopterología. 6(3). e177–e183. 1 indexed citations
9.
Spyropoulos, Alex C., Stuart L. Cohen, Eugenia Gianos, et al.. (2021). Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19. Research and Practice in Thrombosis and Haemostasis. 5(2). 296–300. 27 indexed citations
10.
Spyropoulos, Alex C., Dimitrios Giannis, & Mark Goldin. (2021). Vascular thromboembolic events following COVID‐19 hospital discharge: Incidence and risk factors. Research and Practice in Thrombosis and Haemostasis. 5(5). e12547–e12547. 2 indexed citations
11.
Giannis, Dimitrios, Matthew A. Barish, Mark Goldin, et al.. (2021). Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19. Journal of Thrombosis and Thrombolysis. 51(4). 897–901. 30 indexed citations
12.
Goldin, Mark, Nina Kohn, Michael Qiu, et al.. (2021). External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19. Journal of Thrombosis and Thrombolysis. 52(4). 1032–1035. 25 indexed citations
13.
Ageno, Walter, Renato D. Lópes, Mark Goldin, et al.. (2021). Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older. Journal of Thrombosis and Haemostasis. 19(11). 2772–2780. 5 indexed citations
14.
Sinvani, Liron, Mark Goldin, Nayla Idriss, et al.. (2020). Implementation of Hip Fracture Co‐Management Program ( AGS CoCare: Ortho® ) in a Large Health System. Journal of the American Geriatrics Society. 68(8). 1706–1713. 11 indexed citations
15.
Goldin, Mark, et al.. (2018). Patterns and outcomes of prescribing venous thromboembolism prophylaxis in hospitalized older adults: a retrospective cohort study. Journal of Thrombosis and Thrombolysis. 45(3). 369–376. 4 indexed citations
16.
Mullan, Clancy W., et al.. (2017). Fragmented central venous catheter retained for years with minimal symptoms. Clinical Case Reports. 5(8). 1409–1410. 1 indexed citations
17.
Shah, Sarav S., et al.. (2016). Impact of recent guideline changes on aspirin prescribing after knee arthroplasty. Journal of Orthopaedic Surgery and Research. 11(1). 123–123. 22 indexed citations
18.
Shang, Hong, Xiaoxu Han, Xuanling Shi, et al.. (2011). Genetic and Neutralization Sensitivity of Diverse HIV-1 env Clones from Chronically Infected Patients in China. Journal of Biological Chemistry. 286(16). 14531–14541. 44 indexed citations
19.
Zuo, Teng, Xuanling Shi, Liu Z, et al.. (2011). Comprehensive Analysis of Pathogen-specific Antibody Response in Vivo Based on an Antigen Library Displayed on Surface of Yeast. Journal of Biological Chemistry. 286(38). 33511–33519. 15 indexed citations
20.
Han, Xiaoxu, Di Dai, Bin Zhao, et al.. (2010). Genetic and Epidemiologic Characterization of HIV-1 Infection In Liaoning Province, China. JAIDS Journal of Acquired Immune Deficiency Syndromes. 53(Supplement 1). S27–S33. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan Louw Breakdown of academic impact, for papers by Shu‐Mei Chang Breakdown of academic impact, for papers by Luigi Atripaldi Breakdown of academic impact, for papers by Xiaoqing Wu Breakdown of academic impact, for papers by Ana Luiza Schneider Moreira Breakdown of academic impact, for papers by Mehrdad Rostami Breakdown of academic impact, for papers by Matthew W. McClure Breakdown of academic impact, for papers by Pek Yoon Chong Breakdown of academic impact, for papers by Charlotte Kaeuffer Breakdown of academic impact, for papers by Thor Håkon Skattør
Rankless by CCL
2026